Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Latest news  /  
  • COVID-19 Antibody Reagent

Antibody research reagent now available for coronavirus (COVID-19)

An anti-SARS-CoV-2 antibody research reagent is now available from the National Institute for Biological Standards and Control (NIBSC). This follows previous work by the Institute to develop a SARS-CoV-2 RNA research reagent.

The new antibody reagent is plasma that has been treated to inactivate enveloped viruses and is derived from a donor that has recovered from COVID-19.

It is intended to be used as a positive control for the development and evaluation of serological assays that detect the presence of antibodies against SARS-CoV-2, specifically neutralisation assays and ELISAs.

Information about our additional COVID-19-related reagents and ordering instructions are available here.

 
 
 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap